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Abstract

Cardiac resynchronization therapy (CRT) in multiple and large trials has been
demonstrated to improve symptoms and decrease hospitalization and mortality of patients
when used in addition to optimal medical therapy. The global mechanical performance of
the heart is affected in subjects with heart failure by atrio-ventricular, interventricular, or
intraventricular conduction disorders, which lead to the desynchronization of electrical
activity. Cardiac resynchronization therapy can effectively improve the clinical and
haemodynamic status of these patients.
According to literature data, CRT is performed only on well-selected patients (who
qualify for CRT based on current indications), and approximately 70% of those patients
respond favorably. We present the case of a patient responsive to cardiac
resynchronization therapy which led to lowering of his NYHA classification and to
improvement of left ventricle hemodynamics. The benefits of cardiac resynchronization
therapy were multiple in this case, including improved tolerance to physical exercise and
a decreased rate of hospitalization, which overall led to improved quality of life.
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✓

CRT is best performed only on well-selected patients who qualify based on current
indications, and approximately 70% of patients respond favorably.

✓

CRT improves symptoms and decreases hospitalizations and mortality when used in
addition to optimal medical therapy.
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Introduction

oculomotricity was normal, he presented intact tympanic

membrane bilaterally, mucous membranes moist and
The management of chronic heart failure has the anicteric sclera. His neck did not present any
following primary objectives: symptom relief, preventing lymphadenopathy, carotid bruit, or jugular vein distension.
major morbidity, decreasing mortality, and preventing Regarding the cardiovascular examination, he presented
disease progression by preventing the evolution of the left precordial area with a normal aspect, apical impulse in the
ventricular dysfunction in heart failure clinically objectified VIth left intercostal space outside the left medioclavicular
(1, 2).

line, he had a regular heart rhythm (about 83 beats per
The most common causes leading to heart failure are minute) and a 3/6 systolic murmur in the Vth left intercostal
represented by coronary artery disease (including but not space on the left medioclavicular line, with radiation in the
limited to previous myocardial infarction), atrial fibrillation, axilla and no hepatojugular reflux; peripheral pulse was
high blood pressure, valvular heart disease, infections, present. His blood pressure was 130/80mmHg. Lung
excess alcohol use, and cardiomyopathy related to unknown examination revealed: murmur slightly diminished bilateral
causes. All such causes lead to heart failure by changing the basal, rare rales on both pulmonary areas, no alteration in
structure and/or functioning of the heart. Chronic heart the tactile fremitus and normal percution. The abdomen had
failure is generally a common, expensive, and potentially no pulsatile masses, being non-distended and resonant to
fatal condition for some individuals (3).
percussion; liver and spleen had normal dimensions. I-ntact,
The global mechanical performance of the heart is normal colored and with normal temperature teguments,
affected by heart muscle impairment and conduction cyanosis was not present at the extremities. Neurological
disorders
(atrio-ventricular,
interventricular
or and psychiatric examinations were normal.
intraventricular), which lead to desynchronization of the

Regarding laboratory tests, the patient presented the
electrical activity and thus to heart failure. An effective following: at complete blood count a value of 13.7g/dl for
cardiac resynchronization therapy is generally able to hemoglobin, 42.4% for hematocrit, 6540/mm3 for
improve not only haemodynamic status but also the clinical leukocytes and 163000/mm3 for platelets; a level of blood
condition

of

the

patient.

Benefits

of

cardiac glucose of 168mg/dl; slightly influenced renal function
resynchronization therapy include an improved tolerance to (creatinine of 1.24 mg/dl); and the constants for the hepatic
physical exercise, reduced heart remodeling, decreased function (GOT, GPT, γ-GT, ALP, total, direct and indirect
mortality rate, and a decreased rate of hospitalization in bilirubin), the constants for the lipid profile (total
patients with sinus rhythm (4, 5).
cholesterol, triglycerides, LDL and LDH), and the values of
This paper presents the case of a responder patient to the electrolytes (Na+, K+, Ca++, MG ++, Cl-) were normal.
cardiac resynchronization therapy, characterized by a

His 12-lead electrocardiogram (ECG) before cardiac
significant decrease of symptomatology and substantial resynchronization therapy (CRT) showed a QRS width of
increased capacity for physical effort, thereby improving the 175 ms (Figure 1), while after CRT QRS width was 120 ms
patient’s quality of life.

(Figure 2).

Case Report
Our presentation involves a 66-year-old patient, former
smoker, hypertensive with maximum pressure values of 250
mmHg since 1999, with diabetes since 2004 in treatment
with oral antidiabetic drugs, also known with inferior
myocardial

infarction

in

1996,

anterior

myocardial

infarction in 2013, with ambulatory treatment correctly
taken, who came to the cardiology service for dyspnea of
rest with orthopnea, accompanied by fatigue, headache, and
dizziness.
Regarding his physical examination, the patient was a
fatigued,

well

nourished,

awake

and

orientated,

normocephalic, atraumatic individual with both pupils
equally round and reactive to light and accommodation. His

Figure 1. 12-lead electrocardiogram (ECG) showed
complete left bundle branch block (LBBB) with a QRS
width of 175 ms, before therapy with a cardiac
resynchronization device.
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Figure 2. 12-lead electrocardiogram (ECG) after
cardiac resynchronization therapy (CRT), showed a
QRS width of 120 ms.
Some echocardiographic aspects revealed in the
transthoracic echocardiographic examination before and
after CRT are presented in Figures 3-9.

Figure 3. Assessment of myocardial strain from the
apical four-chamber view, before therapy with a cardiac
resynchronization device.

Figure 4. Two-dimensional echocardiography revealed
a severely impaired left ventricular (LV) function with a
low LV ejection fraction (LVEF) of 10 % assessed
according to the modified Simpson method, before
therapy with a cardiac resynchronization device.

Figure 5. Two-dimensional echocardiography
revealed an improvement in left ventricular (LV)
function with a low LV ejection fraction (LVEF)
of 25 % assessed according to the modified
Simpson method, after therapy with a cardiac
resynchronization device.

Figure 6. Mitral regurgitation (highlighted as
multicolored mosaic pattern, green and yellow),
before therapy with a cardiac resynchronization
device.

Figure 7. Mitral regurgitation (highlighted as
multicolored mosaic pattern, green and yellow),
after therapy with a cardiac resynchronization
device.
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Figure 8. Aspect of waveforms of tissue Doppler
interrogation at the interventricular septum before
therapy with a cardiac resynchronization device (yellow
color).

Figure 9. Aspect of waveforms of tissue Doppler
interrogation at the interventricular septum after therapy
with a cardiac resynchronization device (yellow color).
Coronary arteriography (right radial approach) showed
a right dominant coronary system. Left main coronary artery
diffusely infiltrated, distal stenosis 50%. Left anterior
descending artery with 70% ostial stenosis; 80% proximal
stenosis of the left anterior descending artery appeared on an
ulcerated plaque. 90% marginal I stenosis, important vessel.
Left circumflex artery with 70% stenosis right after the
ostium. Occlusion of the right coronary artery at the origin.
Right coronary artery’s periphery is filled by the
contralateral collateral circulation.
The coronary arteriography showed important
trivascular lesions, graftable vessels. Thus, “off pump”
surgical myocardial revascularization (with high risk) and
subsequently implanting a defibrillator cardioverter with
cardiac resynchronization therapy (CRT-D) were
considered.

Discussion
Hemodynamic effects caused by short left or right
ventricle stimulation were described for the first time about
50 years ago. However, cardiac resynchronization therapy
was firstly applied in 1994, when Cazeau et al. in France

and Bakker in the Netherlands described the first cases of
atrium-biventricular stimulation in patients suffering from
heart failure refractory to drug therapy, having no
indications for cardiac stimulation (4–6).
Desynchronization of the electrical and mechanical
activity of the heart cavities is a pathophysiological process
which directly affects the hemodynamic parameters of the
heart by decreasing the ventricular function, by left
ventricular remodeling, and by worsening heart failure. As a
consequence, the risk of morbidity and mortality rises. For
patients with preexisting cardiomyopathy, the left ventricle
dysfunction is further worsened by atrioventricular and
intraventricular conduction disorders (1). Also, left ventricle
contraction is altered by the existence of the left branch
block, which causes either the delay or the premature
contraction of the parietal segments, thus affecting
myocardial flow distribution and the regional metabolism by
not uniformizing it, and also molecular changes caused by
certain enzymatic systems or by calcium ions (7–9). As with
the patient described in this paper, intraventricular
desynchronization caused by the existence of the left branch
block favors mitral failure and shortens the filling time of
the left ventricle (10, 11).
Many studies have confirmed a significant
improvement in symptomatology and increased exercise
capacity after applying cardiac resynchronization therapy in
patients diagnosed with chronic cardiac failure, also
presenting atrioventricular and intraventricular conduction
disorders, with optimal medical therapy (12-14).
As in our case, the European Society of Cardiology
(ESC) Guidelines for the diagnosis and treatment of acute
and chronic heart failure from 2016 mention that cardiac
resynchronization therapy (CRT) has a 1st Class, A level,
indication in symptomatic patients with heart failure (HF) in
sinus rhythm with QRS duration ≥ 150 ms and LBBB QRS
morphology, and with left ventricular ejection fraction ≤
35%, despite optimal medical therapy, in order to improve
symptoms and reduce morbidity and mortality (15-18).

Conclusions
Cardiac resynchronization therapy (CRT) has been
shown in multiple and large trials that it improves symptoms
and decreases hospitalizations and mortality when used in
addition to optimal medical therapy. CRT is best performed
only on well-selected patients who qualify based on current
indications, and approximately 70% of patients respond
favorably.
The effectiveness of cardiac resynchronization therapy
for the presented case report was confirmed by lowering
NYHA class and by improving the left ventricle’s
hemodynamics. Generally, the benefits of cardiac
resynchronization therapy are multiple, including an
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improved tolerance to physical exercise, reduced heart
remodeling, decreased mortality, and finally a decreased rate
of hospitalization in patients with sinus rhythm.
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